Acetyl L-Carnitine 500 mg

Acetyl L-Carnitine 500 mg

Source Naturals4.7 (639 ratings)
Format:Tablet Quantity: 120 Tablet(s) · 120 servings
Goals
$21.96 $0.18 per serving

Product analysis

59 out of 100

Acetyl L-Carnitine 500 mg offers an economical way to take a single ingredient involved in the body's energy processes. Its effects on everyday energy and focus in healthy adults remain uncertain.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The ingredient is named, but its exact preparation is not fully disclosed. An advantage in absorption or delivery therefore cannot be established.

Ingredient Transparency63

The amount is clearly stated, making serving comparisons easier. More specific form details are omitted, limiting comparisons between preparations.

Value For Money100

The declared amount is economical for the serving price. That price advantage does not resolve the uncertainty around everyday energy or focus benefits.

Customer Satisfaction78

Customer feedback is broadly positive across hundreds of ratings. The review count offers a useful picture of satisfaction without proving health benefits.

Product Focus57

A single ingredient keeps the formula easy to understand. Its connections to energy and brain processes are clearer than evidence for better focus or productivity in healthy adults.

Format
Tablet
Container
120 Tablet(s)
Per serving
$0.18
Customer rating
4.7 · 639 ratings
Report analysis

Goals

Metabolism Support
Impact
Lower effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 500 mg
Study evidence
Mental Focus
Impact
High effect
B- Ingredient FitD- PathwaysB+ EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 500 mg

Acetyl L-carnitine is linked to cellular energy metabolism and acetylcholine-related processes. The saved finding places this serving in cerebral energy supply, but these mechanisms do not establish acute concentration enhancement. The supplied clinical research concerned prolonged use in Alzheimer disease and did not show an overall primary-outcome benefit. It cannot establish a routine focus benefit in healthy adults.

How this product is rated for Mental Focus

Ingredient fit72

Acetyl L-carnitine is the sole ingredient considered for this goal. The 500 mg serving receives a partial saved amount contribution, not a proven acute focus dose.
Goal fit
Acetyl L-carnitine is the sole ingredient considered for this goal.
Dose adequacy
The 500 mg serving receives a partial saved amount contribution, not a proven acute focus dose.

Pathways40

The saved finding concentrates on cerebral energy supply.
Depth
The saved finding concentrates on cerebral energy supply.
Breadth
Cerebral energy supply is the only substantially represented route.

Evidence83

Acetyl L-carnitine leads the saved evidence finding, although the supplied clinical context does not establish healthy acute focus. The ingredient receives the saved studied-preparation finding without establishing acute healthy-adult benefit.
Evidence strength
Acetyl L-carnitine leads the saved evidence finding, although the supplied clinical context does not establish healthy acute focus.
Studied preparation
The ingredient receives the saved studied-preparation finding without establishing acute healthy-adult benefit.

Formulation logic100

Acetyl L-carnitine meets the saved amount threshold. No configured ingredient conflict was identified in the saved findings.
Partner coverage
The credited ingredients work alone or have their required partner in the saved findings.
Conflicts
No configured ingredient conflict was identified in the saved findings.
Effective doses
Acetyl L-carnitine meets the saved amount threshold.
Study evidence
Energy
Impact
High effect
B- Ingredient FitD- PathwaysA+ EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 500 mg

Acetyl L-carnitine has a role in fatty-acid transport, but that mechanism does not establish more everyday energy. Fatigue findings supplied here concern adults over 70 with clinical fatigue. The 500 mg serving cannot be assumed to reproduce those results in other adults.

How this product is rated for Energy

Ingredient fit72

Acetyl L-Carnitine is the product's single assessed ingredient; the energy connection is specific to its role. The assessed amounts provide partial coverage of the saved references, with some ingredients contributing less than others.
Goal fit
Acetyl L-Carnitine is the product's single assessed ingredient; the energy connection is specific to its role.
Dose adequacy
The assessed amounts provide partial coverage of the saved references, with some ingredients contributing less than others.

Pathways40

Mitochondrial energy production is the main covered mechanism, with partial coverage from the assessed ingredients.
Depth
Mitochondrial energy production is the main covered mechanism, with partial coverage from the assessed ingredients.
Breadth
Coverage is concentrated in mitochondrial energy production, rather than extending across several energy mechanisms.

Evidence95

Acetyl L-carnitine evidence is limited to selected clinical fatigue populations; the saved preparation finding does not remove that distinction.
Evidence strength
Acetyl L-Carnitine provides the strongest assessed evidence connection; the population and intended use still limit what benefits can be expected.
Studied preparation
The assessed preparations meet the saved study criteria, without establishing identical effects in every population or regimen.

Formulation logic100

No missing partner or configured conflict was identified. The assessed ingredients meet the saved minimum amount check.
Partner coverage
The assessed ingredients do not depend on a missing partner for their assigned contribution.
Conflicts
No configured ingredient conflict was found in the supplied facts.
Effective doses
All ingredients included in this amount check clear its minimum comparison threshold; that threshold does not itself prove a noticeable benefit.
Study evidence
Brain Health
Impact
High effect
B- Ingredient FitF PathwaysB EvidenceA+ Formulation Logic

Acetyl L-carnitine relates to brain energy metabolism, and the 500 mg serving receives partial amount allowance in the saved comparison. However, energy mechanisms and findings in disease populations do not establish improved cognition in healthy adults. The saved contribution therefore has a narrower scientific interpretation than a claim of routine brain-health benefit.

How this product is rated for Brain Health

Ingredient fit72

Amounts give a mixed or partial overall finding. The formula's focus also depends on its other ingredients and linked goals.
Goal fit
The relevant ingredient content is focused, although the product is linked to several goals.
Dose adequacy
The declared relevant amounts receive partial overall allowance; this reflects the saved comparison rather than a proven benefit threshold.

Pathways19

The saved findings concentrate on brain energy metabolism. That mechanism does not establish healthy-adult cognitive improvement.
Depth
The strongest saved finding concerns brain energy metabolism, with partial coverage.
Breadth
No pathway reaches the saved breadth threshold, despite a partial contribution.

Evidence76

Acetyl L-Carnitine is the strongest contributor to the saved evidence finding. Its scientific limitations still apply despite meeting the saved preparation criteria.
Evidence strength
Acetyl L-Carnitine leads the saved evidence finding. The supplied findings do not establish routine healthy-adult cognitive benefit.
Studied preparation
Qualifying ingredients meet the saved preparation criteria; this does not remove the population and preparation limitations in the supplied science.

Formulation logic100

The saved findings show no unmet partner or matched conflict. Amount thresholds describe the comparison and do not establish combination benefits.
Partner coverage
The relevant ingredients have no unmet required partner in the saved findings; this does not demonstrate added benefit from combining them.
Conflicts
No configured conflict was matched. The caffeine amount penalties were inapplicable; this is not a general safety finding.
Effective doses
All ingredients included in this rule meet its saved amount threshold; that threshold is not a proven effective dose.
Study evidence
Productivity Boost
Impact
Moderate effect
B- Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 500 mgAcetyl L-Carnitine · 500 mg

Acetyl-L-carnitine at 500 mg has a connection to mitochondrial energy processes, but the supplied clinical fatigue evidence comes from a different setting. A routine productivity benefit in healthy working adults remains uncertain.

How this product is rated for Productivity Boost

Ingredient fit72

The ingredient selection is closely focused on the goal's reviewed ingredients. The assessed amounts provide partial alignment with the saved ingredient comparisons.
Goal fit
The ingredient selection is closely focused on the goal's reviewed ingredients.
Dose adequacy
The assessed amounts provide partial alignment with the saved ingredient comparisons.

Pathways14

The strongest saved mechanism is brain energy buffering, with limited coverage. No reviewed mechanism reaches the saved coverage threshold.
Depth
The strongest saved mechanism is brain energy buffering, with limited coverage.
Breadth
No reviewed mechanism reaches the saved coverage threshold.

Evidence67

Acetyl L-Carnitine provides the strongest saved ingredient finding; this does not imply improved work output. The qualifying ingredient preparations match the saved reviewed comparisons.
Evidence strength
Acetyl L-Carnitine provides the strongest saved ingredient finding; this does not imply improved work output.
Studied preparation
The qualifying ingredient preparations match the saved reviewed comparisons.

Formulation logic100

No missing required ingredient partner was identified. No configured conflict was identified in the saved findings. All ingredients assessed for amounts meet the saved minimum comparison level.
Partner coverage
No missing required ingredient partner was identified.
Conflicts
No configured conflict was identified in the saved findings.
Effective doses
All ingredients assessed for amounts meet the saved minimum comparison level.
Study evidence
Longevity
Impact
Moderate effect
B- Ingredient FitF PathwaysC EvidenceA+ Formulation Logic

Acetyl L-carnitine at 500 mg is involved in mitochondrial energy handling through fatty-acid transport. Its relevance to aging remains indirect: the supplied findings on fatigue and cognition do not establish routine preservation of function in healthy adults.

How this product is rated for Longevity

Ingredient fit72

1 ingredients contribute to the saved healthy-aging assessment, with no other active ingredients reducing its focus. The contributing amounts meet only part of the saved dose benchmarks.
Goal fit
1 ingredients contribute to the saved healthy-aging assessment, with no other active ingredients reducing its focus.
Dose adequacy
The contributing amounts meet only part of the saved dose benchmarks.

Pathways11

The strongest recorded contribution concerns mitochondrial energy production. No functional area reaches the saved coverage threshold.
Depth
The strongest recorded contribution concerns mitochondrial energy production.
Breadth
No functional area reaches the saved coverage threshold.

Evidence63

Acetyl L-Carnitine provides the strongest qualifying evidence in the saved assessment; the relevant benefit remains limited to its reviewed outcome. The qualifying ingredients match the preparations used in the saved evidence review.
Evidence strength
Acetyl L-Carnitine provides the strongest qualifying evidence in the saved assessment; the relevant benefit remains limited to its reviewed outcome.
Studied preparation
The qualifying ingredients match the preparations used in the saved evidence review.

Formulation logic100

The contributing ingredients can work alone or have their required partner present. No ingredient conflicts were recorded in the saved assessment. All contributing ingredients reach the saved meaningful-dose threshold.
Partner coverage
The contributing ingredients can work alone or have their required partner present.
Conflicts
No ingredient conflicts were recorded in the saved assessment.
Effective doses
All contributing ingredients reach the saved meaningful-dose threshold.
Study evidence

Ingredients

IngredientAmount per servingScore
Acetyl L-Carnitine HCl
500 mg 95
Gluten Free Adults 18–50 Dairy Free Sugar Free Vegetarian
Report overview
Acetyl L-Carnitine · 500 mg OverallScore95
A- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value
Each serving provides 500 mg of acetyl L-carnitine HCl. The whole-product price works out to about $0.18 per 500 mg of acetyl L-carnitine, a relatively low cost for this ingredient.
How this ingredient is rated

Active Ingredient Quality & Bioavailability88

Acetyl L-carnitine is the only carnitine form identified in the available facts. The available facts identify the HCl form and record no purity or manufacturing claim.
ALCAR vs. Standard Carnitine Form
Acetyl L-carnitine is the only carnitine form identified in the available facts.
Advanced Sourcing and Salt Specificity
The available facts identify the HCl form and record no purity or manufacturing claim.

Dose, Safety & Label Transparency100

Each serving contains 500 mg of acetyl L-carnitine, with its amount individually disclosed.
Clinical Dosage Efficacy
A serving provides 500 mg of acetyl L-carnitine.
Label Transparency and Proprietary Blends
The 500 mg amount of acetyl L-carnitine per serving is individually disclosed.

Value100

The whole-product price works out to about $0.18 per 500 mg of acetyl L-carnitine, a relatively low cost for this ingredient.
Price per 500mg Acetyl L-Carnitine
The whole-product price works out to about $0.18 per 500 mg of acetyl L-carnitine, a relatively low cost for this ingredient.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  2. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  3. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  4. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  5. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  6. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  7. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  8. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsEnergy forAcetyl L-Carnitine
  9. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
    Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Randomized trial60 participantsEnergy forAcetyl L-Carnitine
  10. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G · Scandinavian journal of gastroenterology · 2011
    Randomized trial67 participantsEnergy forAcetyl L-Carnitine
  11. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y · Experimental and therapeutic medicine · 2020
    Randomized trial239 participantsEnergy forAcetyl L-Carnitine
  12. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
    Kumar R; Nuñez NA; Joshi N; Joseph B; Verde A; Seshadri A; Cuellar Barboza AB; Prokop LJ; Medeiros GC; Singh B · Bipolar disorders · 2024
    Systematic reviewEnergy forAcetyl L-Carnitine
  13. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
    Malaguarnera G; Catania VE; Bertino G; Chisari LM; Castorina M; Bonfiglio C; Cauli O; Malaguarnera M · Current pharmaceutical design · 2022
    Randomized trial92 participantsLongevity forAcetyl L-Carnitine
  14. Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
    Malaguarnera G; Pennisi M; Gagliano C; Vacante M; Malaguarnera M; Salomone S; Drago F; Bertino G; Caraci F; Nunnari G; Malaguarnera M · Hepatitis monthly · 2014
    Randomized trial62 participantsMental Focus Productivity Boost forAcetyl L-Carnitine
  15. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
    Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B · La Clinica terapeutica · 1992
    Non-randomized trial17 participantsMental Focus forAcetyl L-Carnitine
  16. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
    Arnold LE; Amato A; Bozzolo H; Hollway J; Cook A; Ramadan Y; Crowl L; Zhang D; Thompson S; Testa G; Kliewer V; Wigal T; McBurnett K; Manos M · Journal of child and adolescent psychopharmacology · 2008
    Randomized trial112 participantsMental Focus forAcetyl L-Carnitine
  17. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE · The Cochrane database of systematic reviews · 2019
    Meta-analysis398 participants5 studies pooledMental Focus forAcetyl L-Carnitine
  18. Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism.
    Krims-Davis K; Ozola M; Razzivina V; Gukalova B; Konrade I; Dambrova M; Liepinsh E · Molecular nutrition & food research · 2025
    Randomized trialMetabolism Support forAcetyl L-Carnitine